Cargando…

Medical expenditure trajectory and HbA1c progression prior to and after clinical diagnosis of type 2 diabetes in a commercially insured population in the USA

INTRODUCTION: Medical expenditures of individuals with type 2 diabetes escalate before clinical diagnosis. How increases in medical expenditures are related to glucose levels remains unclear. We examined changes in HbA1c and medical expenditures in years prior to and shortly after type 2 diabetes di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pagán, Lorissa, Yang, Wenya, Shao, Hui, Wang, Yu, Zhang, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Epidemiology/Health services research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626875/ https://www.ncbi.nlm.nih.gov/pubmed/37914345 http://dx.doi.org/10.1136/bmjdrc-2023-003397

Ejemplares similares

Trajectories in HbA1c and other risk factors among adults with type 1 diabetes by age at onset
por: Edqvist, Jon, et al.
Publicado: (2021)

Relationship of HbA1c variability, absolute changes in HbA1c, and all-cause mortality in type 2 diabetes: a Danish population-based prospective observational study
por: Skriver, Mette V, et al.
Publicado: (2015)

Empirically Establishing Blood Glucose Targets to Achieve HbA(1c) Goals
por: Wei, Nancy, et al.
Publicado: (2014)

HbA(1c) and Coronary Heart Disease Risk Among Diabetic Patients
por: Zhao, Wenhui, et al.
Publicado: (2014)

Sleep characteristics and HbA1c in patients with type 2 diabetes on glucose-lowering medication
por: Tan, Xiao, et al.
Publicado: (2020)

HbA(1c) as a Predictor of Diabetes and as an Outcome in the Diabetes Prevention Program: A Randomized Clinical Trial
Publicado: (2015)

Undiagnosed diabetes based on HbA(1c) by socioeconomic status and healthcare consumption in the Tromsø Study 1994–2016
por: Ruiz, Paz Lopez-Doriga, et al.
Publicado: (2021)

The Impact of Carbamylation and Anemia on HbA(1c)’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease
por: Tang, Mengyao, et al.
Publicado: (2023)

Derivation and external validation of a clinical version of the German Diabetes Risk Score (GDRS) including measures of HbA1c
por: Mühlenbruch, Kristin, et al.
Publicado: (2018)

Experience of point-of-care HbA1c testing in the English National Health Service Diabetes Prevention Programme: an observational study
por: Barron, Emma, et al.
Publicado: (2020)

Effect of the interaction between physical activity and estimated macronutrient intake on HbA1c: population-based cross-sectional and longitudinal studies
por: Furukawa, Takuma, et al.
Publicado: (2022)

Development of a 5-year risk prediction model for type 2 diabetes in individuals with incident HbA1c-defined pre-diabetes in Denmark
por: Nicolaisen, Sia K, et al.
Publicado: (2022)

Assessment of diabetes and prediabetes prevalence and predictors by HbA1c in a population from sub-Saharan Africa with a high proportion of anemia: a prospective cross-sectional study
por: Hodel, Nikolai Carl, et al.
Publicado: (2020)

Does cancer risk increase with HbA(1c), independent of diabetes?
por: de Beer, J C, et al.
Publicado: (2014)

Glycated hemoglobin (HbA1c) as diagnostic criteria for diabetes: the optimal cut-off points values for the Pakistani population; a study from second National Diabetes Survey of Pakistan (NDSP) 2016–2017
por: Basit, Abdul, et al.
Publicado: (2020)

Assessing widening disparities in HbA1c and systolic blood pressure retesting during the COVID-19 pandemic in an LGBTQ+-focused federally qualified health center in Chicago: a retrospective cohort study using electronic health records
por: Rivera, Adovich S, et al.
Publicado: (2022)

Associations between adolescent experiences, parent experiences and HbA1c: results following two surveys based on the Norwegian Childhood Diabetes Registry (NCDR)
por: Iversen, Hilde Hestad, et al.
Publicado: (2019)

New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer
por: Lu, Yunxia, et al.
Publicado: (2015)

IDF2022-0948 Health Inequality and its link to HbA1c Test Recovery in a Developed Health Economy: In a ‘Nearly Post COVID-19’ World
por: Fryer, A., et al.
Publicado: (2023)

Trends in Health Care Expenditure in U.S. Adults With Diabetes: 2002–2011
por: Ozieh, Mukoso N., et al.
Publicado: (2015)

New directions in incidence and prevalence of diagnosed diabetes in the USA
por: Benoit, Stephen R, et al.
Publicado: (2019)

The economic burden of NIPC and BOS following allogeneic HSCT in patients with commercial insurance in the United States
por: Sacks, Naomi C., et al.
Publicado: (2022)

Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance
por: Johnson, Kate M., et al.
Publicado: (2022)

Diabetes mellitus among adults with tuberculosis in the USA, 2010–2017
por: Armstrong, Lori R, et al.
Publicado: (2020)

Performance of Comorbidity, Risk Adjustment, and Functional Status Measures in Expenditure Prediction for Patients With Diabetes
por: Maciejewski, Matthew L., et al.
Publicado: (2009)

The Impact of Commercial Health Plan Prior Authorization Programs on the Utilization of Services for Low Back Pain
por: Goodman, Robert M., et al.
Publicado: (2016)

An Analysis of Catastrophic Out-of-Pocket Health Expenditures in Ghana
por: Sataru, Fuseini, et al.
Publicado: (2022)

Diabetes as an increasingly common comorbidity among patient hospitalizations for tuberculosis in the USA
por: Zahr, Roula S, et al.
Publicado: (2016)

Correlates of second-line type 2 diabetes medication selection in the USA
por: Ackermann, Ronald T, et al.
Publicado: (2017)

Health Beliefs Associated With Metformin Use Among Insured Adults With Prediabetes
por: McEwen, Laura N., et al.
Publicado: (2022)

Trends in type 2 diabetes detection among adults in the USA, 1999–2014
por: Geiss, Linda S, et al.
Publicado: (2018)

Serum α-hydroxybutyrate (α-HB) predicts elevated 1 h glucose levels and early-phase β-cell dysfunction during OGTT
por: Varvel, Stephen A, et al.
Publicado: (2014)

Type 2 diabetes medication and HbA1c levels in North Karelia Finland, 2013–2019
por: Wikström, Katja, et al.
Publicado: (2022)

Association of visit-to-visit HbA1c variability with cardiovascular diseases in type 2 diabetes within or outside the target range of HbA1c
por: Sun, Bao, et al.
Publicado: (2022)

Incidence of diabetes and prediabetes and predictors of glycemic change among South Asians in the USA: the MASALA study
por: Gujral, Unjali P, et al.
Publicado: (2020)

Life Years Lost and Lifetime Health Care Expenditures Associated With Diabetes in the U.S., National Health Interview Survey, 1997–2000
por: Leung, Man-Yee Mallory, et al.
Publicado: (2015)

Patterns and correlates of use of evidence-based interventions to control diabetes by local health departments across the USA
por: Tabak, Rachel G, et al.
Publicado: (2018)

Long-term mortality among kidney transplant recipients with and without diabetes: a nationwide cohort study in the USA
por: Harding, Jessica L, et al.
Publicado: (2021)

Impact of Public Health Insurance on Out-of-Pocket Health Expenditures of the Near-Poor in Vietnam
por: Duc Thanh, Nguyen, et al.
Publicado: (2021)

Factors Associated With Coverage of Health Insurance Among Women in Malawi
por: Chauluka, Margaret, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7g1qmq9d5ujjge4i5b2tg61mgs